Plenary Sessions
Saturday, 12 July - Wednesday, 16 July 2003

Last updated 05 May 2009
Saturday, 12 July
08:20 - 09:00		 Lauterbur Lecture: The Legacy of I.I. Rabi
Each year the ISMRM Scientific Meeting opens with the Lauterbur Lecture in recognition of the contributions of Paul Lauterbur to the field of magnetic resonance.  At this 11th Annual Meeting, the lecture will focus on the legacy of Isadore Rabi, whose early observations on molecular beam resonance were fundamental to the development of our field and won him the Nobel Physics Prize in 1944.  The lecture will discuss the many facets of Isadore Rabi and will be given by his former PhD student and colleague Norman Ramsey, who also won the Nobel Prize in Physics in 1989.
 Norman F. Ramsey, Ph.D., Harvard University, Cambridge, MA, USA
09:00 - 09:25 Toronto Keynote Lecture: Future Directions in Funded Biomedical Imaging Research
This year, in recognition of the establishment in the United States of the first dedicated national biomedical imaging institute, Dr. Roderic Pettigrew, the inaugural director, will present a keynote lecture outlining the future development of programs and initiatives for biomedical imaging research.		 Roderic I. Pettigrew, M.D., Ph.D., National Institute for Biomedical Imaging and Bioengineering, NIH, Bethesda, MD, USA
Imaging in Chronic Disease
Saturday, 12 July 2003, 09:25 - 10:15
Garry E. Gold, M.D., Clifford R. Jack, M.D.,  and James F.M. Meaney, Organizers
Educational Objectives:   Upon completion of this session, participants should be able to:
Recognize the role played by imaging in the treatment and monitoring of chronic diseases such as epilepsy, Alzheimer's, and arthritis;
 Evaluate the advances in MRI that allow for improved assessment of chronic disease;
 Recommend new MRI techniques for studying chronic disease at their institution;
Interpret new techniques, such as spectroscopy and T2-mapping, in the evaluation of chronic disease.
09:25 Neurodegenerative Diseases and Epilepsy Michael Weiner, M.D., University of California, San Francisco, CA, USA
09:50 The Burden of (Musculoskeletal) Disease: Challenges on Imaging for Diagnosis and Prognosis Maarten Boers, Ph.D., M.D., VU Medical Center, Amsterdam, The Netherlands
Safety and MRI
Sunday, 13 July 2003, 08:15 - 09:30
Kim Butts, Ph.D., David J. Lomas, M.D., and Michael B. Smith, Ph.D., Organizers
Educational Objectives:  Upon completion of this session, participants should be able to:
Identify the physiological limits of MRI;
 Evaluate an epidemiological study on MRI;
 Identify who makes recommendations on MRI guidelines;
 List MRI regulations.
08:15 Physiological Limits of MR John Schenck, M.D., Ph.D., General Electric Corporate R&D, Schenectady, NY, USA
08:40 Clinical Safety Issues Donald M. Hadley, M.B.Ch.B., Ph.D., Institute of Neurological Sciences, Glasgow, Scotland, UK
09:05 Gradient Safety Concerns Brian K. Rutt, Ph.D., Imaging Research Laboratories, Robarts Research Institute, London, ON, Canada
The RF Renaissance
Monday, 14 July 2003, 08:15 - 09:30
Peter S. Allen, Ph.D., Rolf Gruetter, Ph.D., Michael B. Smith, Ph.D., and Daniel K. Sodickson, M.D., Ph.D., Organizers
Educational Objectives:   Upon completion of this session, participants should be able to:
Understand the complexity and diversity of the evolution of coil design;
 Identify and explain the scientific requirements and challenges for coil development at high fields;
 Describe the theory and implementation of parallel imaging.
08:15 A History of RF Coils Eiichi Fukishima, New Mexico Resonance, Albuquerque, NM, USA
08:40 Development and Challenges of High Field Probes David I. Hoult, D.Phil., National Research Council, Winnipeg, Manitoba, Canada
09:05 Parallel MRI: Breaking the Acquisition Speed Limit Using RF Coil Arrays Joseph Hajnal, Imperial College, London, England, UK
Evaluation of Ischemic Heart Disease by MRI
Tuesday, 15 July 2003, 08:15 - 09:30
Zahi A. Fayad, Ph.D.,  P.V. Prasad, Ph.D., and Martin R. Prince, M.D., Ph.D., Organizers
Educational Objectives:   Upon completion of this session, participants should be able to:
Define current state of the art in the evaluation of ischemic heart disease by MRI;
 Select appropriate protocols for the evaluation of ischemic heart disease;
 Interpret MRI data used in the evaluation of ischemic heart disease;
 Appraise future developments in MRI applications to the evaluation of ischemic heart disease;
 Recommend appropriate tests for the evaluation of ischemic heart disease by MRI.
08:15 Current State of the Art Steven D. Wolff, M.D., Ph.D., Lenox Hill Hospital, New York, NY, USA
08:40 What's on the Horizon Richard D. White, M.D., The Cleveland Clinics, Cleveland, OH, USA
09:05 What Does the Future Behold? Elliot R. McVeigh, Ph.D., National Heart, Lung, and Blood Institute, NIH, Bethesda, MD, USA

The Tumor Microenvironment
Wednesday, 16 July 2003, 08:15 - 09:30
Jeffrey L. Evelhoch, Ph.D., John R. Griffiths, M.B.B.S., D. Phil., and Michal Neeman, Ph.D., Organizers
Educational Objectives:  Upon completion of this session, participants should be able to:
Describe several key physiological aspects of the tumor microenvironment and explain why it is important to be able to assess them;
 List several MRI, MRS and EPR methods which have been used to examine key aspects of the tumor microenvironmental pathophysiology;
 Explain how results of studies using these magnetic resonance methods have impacted our understanding of tumor microenvironmental pathophysiology.
08:15 Mechanisms Underlying Tumor Microenvironmental Pathophysiology Mark W. Dewhirst, D.V.M., Ph.D., Duke University Medical Center, Durham, NC, USA
08:40 MRI and MRS Studies of Tumor Pathophysiology Robert J. Gillies, Ph.D., University of Arizona, Tucson, AZ, USA
09:05 EPR Studies of Tumor Oxygenation Bernard Gallez, Ph.D., Université, Catholique de Louvain, Brussels, Belgium